Celldex Therapeutics buy BiotechBee
Start price
07.09.22
/
80%
€29.80
Target price
31.12.25
€50.00
Performance (%)
-18.12%
End price
14.12.24
€24.40
Summary
This prediction ended on 14.12.24 with a price of €24.40. The price of Celldex Therapeutics has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.12%. BiotechBee has 80% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Celldex Therapeutics | -4.762% | -4.762% | -5.512% | -31.232% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
According to BiotechBee what are the pros and cons of Celldex Therapeutics for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Celldex Therapeutics diskutieren
Buy mit Kursziel 50,0